Analysis of MGMT promoter methylation revealed higher PD-L1 expression in MGMT methylated glioma (mean amounts of 30%) compared with MGMT unmethylated glioma (mean amounts of 26%, Fig. 3d). Here, MGMT is linked to central nervous system cancer.